Skip to main content
Home
  • ALL Specialities ALL Specialities
    Home
    Home

    Error message

    • Deprecated function: Return type of DatabaseStatementBase::execute($args = [], $options = []) should either be compatible with PDOStatement::execute(?array $params = null): bool, or the #[\ReturnTypeWillChange] attribute should be used to temporarily suppress the notice in require_once() (line 2246 of /var/www/webmd/apps/mdedge/htdocs/includes/database/database.inc).
    • Deprecated function: Return type of DatabaseStatementEmpty::current() should either be compatible with Iterator::current(): mixed, or the #[\ReturnTypeWillChange] attribute should be used to temporarily suppress the notice in require_once() (line 2348 of /var/www/webmd/apps/mdedge/htdocs/includes/database/database.inc).
    • Deprecated function: Return type of DatabaseStatementEmpty::next() should either be compatible with Iterator::next(): void, or the #[\ReturnTypeWillChange] attribute should be used to temporarily suppress the notice in require_once() (line 2348 of /var/www/webmd/apps/mdedge/htdocs/includes/database/database.inc).
    • Deprecated function: Return type of DatabaseStatementEmpty::key() should either be compatible with Iterator::key(): mixed, or the #[\ReturnTypeWillChange] attribute should be used to temporarily suppress the notice in require_once() (line 2348 of /var/www/webmd/apps/mdedge/htdocs/includes/database/database.inc).
    • Deprecated function: Return type of DatabaseStatementEmpty::valid() should either be compatible with Iterator::valid(): bool, or the #[\ReturnTypeWillChange] attribute should be used to temporarily suppress the notice in require_once() (line 2348 of /var/www/webmd/apps/mdedge/htdocs/includes/database/database.inc).
    • Deprecated function: Return type of DatabaseStatementEmpty::rewind() should either be compatible with Iterator::rewind(): void, or the #[\ReturnTypeWillChange] attribute should be used to temporarily suppress the notice in require_once() (line 2348 of /var/www/webmd/apps/mdedge/htdocs/includes/database/database.inc).

    Michele G. Sullivan

    News

    Mild cognitive impairment risk slashed by 19% in SPRINT MIND

    Author:
    Michele G. Sullivan
    Publish date: July 25, 2018

    Clinicians are calling blood pressure drugs the first disease-modifying therapy for MCI.

    • Read More

    News

    Pregnancy and years of reproductive capability linked to dementia risk

    Author:
    Michele G. Sullivan
    Publish date: July 23, 2018

    CHICAGO – The findings suggest that lifelong estrogen exposure may exert a neuroprotective effect in women.

    • Read More

    News

    Gates Foundation, Lauder family launch $30 million Alzheimer’s biomarker search

    Author:
    Michele G. Sullivan
    Publish date: July 23, 2018

    The Alzheimer’s Disease Drug Discovery Foundation will award grants for research into novel peripheral...

    • Read More

    News

    Dementia epidemiology in LGB community examined for first time

    Author:
    Michele G. Sullivan
    Publish date: July 23, 2018

    CHICAGO – Depression, which was much more common in the LGB group than in a heterosexual comparator group,...

    • Read More

    News

    Breast cancer patients don’t get the financial counseling they want from their clinicians

    Author:
    Michele G. Sullivan
    Publish date: July 23, 2018

    About half of medical oncologists, and fewer surgeons and radiation oncologists, have someone in their practice to discuss the financial...

    • Read More

    News

    Deaths from liver disease surged in U.S. since 1999

    Author:
    Michele G. Sullivan
    Publish date: July 19, 2018

    Deaths from cirrhosis increased by 65.4% and deaths from hepatocellular carcinoma by 117%.

    • Read More

    News

    New PET imaging agent shows loss of synaptic density in Alzheimer’s brains

    Author:
    Michele G. Sullivan
    Publish date: July 17, 2018

    Synaptic density loss seen with the marker also correlated with episodic memory.

    • Read More

    News

    About half of FDA expedited approvals lack double-blind trials

    Author:
    Michele G. Sullivan
    Publish date: July 17, 2018

    An analysis calculates how much evidence actually supports the speedy approvals granted for certain life-threatening conditions.

    • Read More

    News

    Better ICU staff communication with family may improve end-of-life choices

    Author:
    Michele G. Sullivan
    Publish date: July 17, 2018

    The intervention didn’t reduce surrogates’ emotional distress, but it was associated with shorter ICU stays and...

    • Read More

    News

    AGA Clinical Practice Update: Statins are safe, effective, and important for most patients with liver disease and dyslipidemia

    Author:
    Michele G. Sullivan
    Publish date: July 13, 2018

    With a few exceptions, patients with liver disease should receive lipid-lowering agents at full dose.

    • Read More

    News

    Fluoroquinolones can cause fatal hypoglycemia, FDA warns

    Author:
    Michele G. Sullivan
    Publish date: July 11, 2018

    The FDA is strengthening warning labels on fluoroquinolones to reflect the risk of life-threatening hypoglycemia...

    • Read More

    News

    Antiamyloid antibody slowed Alzheimer’s progression while clearing brain amyloid

    Author:
    Michele G. Sullivan
    Publish date: July 10, 2018

    Details won’t be released until July 25 at the Alzheimer’s Association International Conference, but Eisai and Biogen say BAN2401 hit its clinical...

    • Read More

    News

    ICD use curbed in hospitals named in federal lawsuit

    Author:
    Michele G. Sullivan
    Publish date: July 5, 2018

    After the DOJ announced a suit against 500 hospitals for the inappropriate use of ICDs for primary prevention,...

    • Read More

    News

    HPV testing detects cervical precancers earlier than cytology

    Author:
    Michele G. Sullivan
    Publish date: July 3, 2018

    The HPV FOCAL study compared Pap liquid-based cytology with primary HPV testing.

    • Read More

    News

    New look at ATLAS suggests rivaroxaban may still have role in ACS

    Author:
    Michele G. Sullivan
    Publish date: July 2, 2018

    A reanalysis of the ATLAS ACS 2-TIMI 51 trial separated fatal and nonfatal events.

    • Read More

    Pages

    • « first
    • …
    • 7
    • 8
    • 9
    • 10
    • 11
    • 12
    • 13
    • 14
    • 15
    • …
    • last »

    Privacy Policy

    Terms of Use

    Editorial Policy

    Cookie Policy

    Ad Policy

    Medscape Customer Support

    Frequently Asked Questions

     

    Advertise with MDedge

    See more with MDedge! See our Other Publications

    MDedge: Keeping You Informed. Saving You Time.

    Copyright  © 2023 Frontline Medical Communications Inc., 283-299 Market Street, 2 Gateway Center, 4th Floor, Newark, NJ 07102. All rights reserved. Unauthorized use prohibited. The information provided is for educational purposes only. Use of this Web site is subject to the medical disclaimer.

    • All Specialties
      • MDedge Home
      • Cardiology
      • Clinician Reviews
      • Dermatology
      • Emergency Medicine
      • Endocrinology/Diabetes
      • Family Medicine
      • Federal Practitioner
      • Gastroenterology
      • Hematology/Oncology
      • Infectious Disease
      • Internal Medicine
      • Neurology
      • Obstetrics And Gynecology
      • Pediatrics
      • Psychiatry
      • Pulmonology
      • Rheumatology
      • Surgery
    • MDedge Home
    • Cardiology
    • Clinician Reviews
    • Dermatology
    • Emergency Medicine
    • Endocrinology/Diabetes
    • Family Medicine
    • Federal Practitioner
    • Gastroenterology
    • Hematology/Oncology
    • Infectious Disease
    • Internal Medicine
    • Neurology
    • Obstetrics And Gynecology
    • Pediatrics
    • Psychiatry
    • Pulmonology
    • Rheumatology
    • Surgery